Application of cfDNA in non-invasive diagnosis of early breast cancer
A breast cancer, diagnostic model technology, applied in the field of biomedicine, can solve the problems of low specificity, poor observer consistency, high false-positive biopsy rate, and achieve high sensitivity, high ctDNA enrichment, and reliable results.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment
[0080] 1. Research object
[0081] Select from April 1, 2019 to August 31, 2019 in Cancer Hospital of Chinese Academy of Medical Sciences and Peking Union Medical College Hospital (CHCAMS, n = 160, training set) and Cancer Hospital Affiliated to Harbin Medical University (HMUCH, n = 50, validation set ) 210 cases of BI-RADS4 lesions found by conventional ultrasonography, all patients were female, all patients underwent mammography and ultrasonography, and all patients were confirmed by surgery or biopsy pathological examination. In this study, the age, imaging appearance, pathological features, molecular subtype, stage and serum tumor markers such as carcinoembryonic antigen (CEA) and cancer antigen 15-3 (CA15-3) of the patients in the training set and validation set were compared. Perform phenotypic analysis. Two experienced radiologists at each center interpreted images and classified them according to the fifth edition of the BI-RADS classification. CEA and CA15-3 analyze...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com